Ionis Pharmaceuticals Inc...

NASDAQ: IONS · Real-Time Price · USD
43.76
0.91 (2.12%)
At close: Aug 15, 2025, 3:59 PM
43.97
0.49%
After-hours: Aug 15, 2025, 07:55 PM EDT

Ionis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
242.08M 399.27M 1.99B 2.12B
Short-Term Investments
2.06B 1.93B 1.71B 1.25B
Long-Term Investments
41.02M 42.99M 40.37M 15.62M
Other Long-Term Assets
86.25M 62.29M 34.63M 59.99M
Receivables
92.19M 97.78M 25.54M 61.9M
Inventory
12.51M 28.43M 22.03M 24.81M
Other Current Assets
217.93M 184.45M 157.72M 125.17M
Total Current Assets
2.62B 2.64B 2.2B 2.35B
Property-Plant & Equipment
256.11M 242.94M 256M 178M
Goodwill & Intangibles
n/a n/a n/a 29M
Total Long-Term Assets
383.38M 348.22M 331M 267M
Total Assets
3B 2.99B 2.53B 2.61B
Account Payables
42.96M 26.03M 17.92M 11.9M
Deferred Revenue
78.99M 151.13M 91M 98M
Short-Term Debt
9.28M 53.16M 7.54M 3.53M
Other Current Liabilities
n/a 147.89M 140.1M 88.56M
Total Current Liabilities
309.32M 448.09M 312M 241M
Long-Term Debt
1.79B 1.74B 1.18B 1.16B
Other Long-Term Liabilities
n/a n/a n/a 67.09M
Total Long-Term Liabilities
2.11B 2.16B 1.65B 1.6B
Total Liabilities
2.42B 2.6B 1.96B 1.84B
Total Debt
1.96B 1.45B 1.34B 1.16B
Common Stock
158K 144K 142K 141K
Retained Earnings
-2.25B -1.8B -1.43B -1.16B
Comprehensive Income
-30.81M -32.65M -57.48M -32.67M
Shareholders Equity
588.35M 386.69M 573M 772M
Total Investments
2.06B 1.98B 1.71B 1.25B